Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MARINOL 2.5 MG

DRONABINOL : 2.5 MG · DIN 00611190 · ABBOTT LABORATORIES, LIMITED

Health Canada status: CANCELLED POST MARKET

What is MARINOL?

MARINOL 2.5 MG contains DRONABINOL : 2.5 MG. It is listed in the Health Canada Drug Product Database under DIN 00611190, held by ABBOTT LABORATORIES, LIMITED, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 24-Feb-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is MARINOL used for?

AIDS-related anorexia associated with weight loss; severe nausea and vomiting associated with cancer chemotherapy in adults.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN00611190
Brand nameMARINOL
Generic / active ingredientDRONABINOL : 2.5 MG
ManufacturerABBOTT LABORATORIES, LIMITED
Strength2.5 MG
Dosage formCAPSULE
Route of administrationORAL
SchedulePrescription
ATC codeA04AD10 DRONABINOL
AHFS class56:92.00
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date24-Feb-2012
Original market date1994-12-31 00:00:00

How is it administered?

AIDS anorexia: Start 2.5 mg BID. Antiemetic: Initial 5 mg/m2 1-3h before chemo, then every 2-4h (4-6 doses/day). Titrate based on response and tolerability.

Included because it drives pack selection and wastage. Consult the monograph.

How is it stored and handled?

Not specified in the provided text (refer to Storage and Stability section 17).

How is it supplied?

Not explicitly detailed in provided text (mentions 2.5 mg and 5 mg strengths).

Contraindications

Allergy to marijuana/cannabinoids/sesame oil; significant hepatic/renal impairment; serious cardiovascular disease; history of schizophrenia/psychosis; children <18; pregnancy/nursing.

Warnings and precautions

Potential for abuse/dependence. CNS effects (intoxication, dizziness, confusion). Do not drive. Cardiovascular effects (tachycardia, hypotension). Caution in patients with history of epilepsy.

What can be used instead?

Other Canadian products sharing ATC code A04AD10 DRONABINOL. 0 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
MARINOL5 MGCAPSULEABBOTT LABORATORIES, LIMITEDCANCELLED POST MARKETDIN 00611204
MARINOL CAP 10MG10 MGCAPSULESOLVAY PHARMA INCCANCELLED POST MARKETDIN 00611212

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for MARINOL

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for MARINOL

Health Canada Drug Product Database (DPD), DIN 00611190. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.